First National Bank Sioux Falls Has $799,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

First National Bank Sioux Falls reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,525 shares of the healthcare conglomerate’s stock after selling 100 shares during the period. First National Bank Sioux Falls’ holdings in UnitedHealth Group were worth $799,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Geode Capital Management LLC raised its position in UnitedHealth Group by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate’s stock valued at $10,068,869,000 after purchasing an additional 319,515 shares in the last quarter. Capital International Investors grew its stake in shares of UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock worth $7,899,905,000 after buying an additional 906,365 shares during the last quarter. Norges Bank bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $6,375,744,000. Northern Trust Corp grew its stake in shares of UnitedHealth Group by 12.5% during the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate’s stock worth $4,807,527,000 after buying an additional 1,058,488 shares during the last quarter. Finally, Franklin Resources Inc. grew its stake in shares of UnitedHealth Group by 10.7% during the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate’s stock worth $4,514,178,000 after buying an additional 861,854 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 0.0%

UnitedHealth Group stock opened at $303.08 on Tuesday. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The firm has a 50 day moving average price of $404.62 and a 200-day moving average price of $480.59. The company has a market capitalization of $274.94 billion, a P/E ratio of 19.55, a P/E/G ratio of 1.37 and a beta of 0.44. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the company earned $6.91 earnings per share. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be issued a $2.21 dividend. The ex-dividend date of this dividend is Monday, June 16th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 2.92%. UnitedHealth Group’s dividend payout ratio (DPR) is 37.02%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research reports. Erste Group Bank cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 30th. Royal Bank of Canada reduced their price objective on shares of UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating on the stock in a research note on Friday, May 16th. Argus cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, April 21st. Wells Fargo & Company reissued an “overweight” rating on shares of UnitedHealth Group in a research note on Friday. Finally, JPMorgan Chase & Co. reduced their price objective on shares of UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating on the stock in a research note on Thursday, May 15th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $428.43.

Insider Buying and Selling

In other news, Director Kristen Gil bought 3,700 shares of the stock in a transaction on Thursday, May 15th. The shares were acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the purchase, the director now directly owns 3,818 shares of the company’s stock, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Stephen J. Hemsley bought 86,700 shares of the stock in a transaction on Friday, May 16th. The stock was purchased at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the purchase, the chief executive officer now directly owns 679,493 shares in the company, valued at approximately $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 109,408 shares of company stock valued at $31,607,768. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.